Fwd: Experimental chikungunya vaccine induces robust antibody response

---------- Forwarded message ----------
From: National Institutes of Health (NIH) <nih.ocpl@service.govdelivery.com>
Date: Fri, Aug 15, 2014 at 6:08 AM
Subject: Experimental chikungunya vaccine induces robust antibody response
To: iammejtm@gmail.com

Having trouble viewing this email? View it as a Web page. You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).   Experimental chikungunya vaccine induces robust antibody response 08/15/2014 08:14 AM EDT Vaccine developed by NIH scientists performs well in early clinical trial. Update Your E-mail Address | Add Subscriptions | Unsubscribe If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact NIHinfo@od.nih.gov. Before writing, please view our Frequently Asked Questions page, our A-Z Health Topics page, or Search our website. This service is provided to you by the National Institutes of Health. NIH…Turning Discovery Into Health®  This email was sent to iammejtm@gmail.com using GovDelivery, on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612

--
Jeremy Tobias Matthews